Study to Detect the Predictive Capacity of a Composite Biological Marker in the Success of Embryonic Implantation in Fertilization Treatments in Vitro (IVF): Seedchrony Pilot.
In Vitro Fertilization (IVF) success is below 40%, with Embryo Transfer the leading cause of IVF failure. This clinical investigation aims to evaluate if the levels of an intrauterine biomarker dissolved in the uterine fluid (alone or as a complex biological marker) can predict the outcome of embryo transfer.
• First IVF cycle patients
• Patients who sign the informed consent form
• Patients between 18 and 37 years old.
• Patients BMI ≤ 30
• Patients who have frozen blastocysts of good quality (grade A or B)
• Patients with negative vaginal and endocervical cultures
• Patients with an antimullerian hormone level greater than 1 ng/mL.
• IVF patients with an endometrial thickness greater than 7mm with trilaminar pattern on the day of the pre-progesterone visit.
• And who meets one of these conditions:
‣ Not having had a previous embryo transfer.
⁃ Have failed only one embryo transfer